ISAR Bioscience is sponsor of BioVaria 2019, Europe’s leading showcasing event for life science technologies. ISAR is committed to translational R&D in the field of applied stem cell and regenerative medicine research. ISAR invites scientists and R&D organizations to submit early-stage or more advanced translational R&D project proposals for recognition, support & funding. All areas of applied biomedical and therapeutic research are welcome but R&D project proposals must encompass ISAR key technologies such as for instance hiPSC and cell differentiation, genome engineering, next generation disease models for therapeutic discovery and regenerative medicine, cell-based models for industrial biotechnology applications, 3D spheroid/organoid tissue models, microfluidics, or laboratory automation. Confidentiality is guaranteed and all proposals will be internally evaluated. Select applicants will be invited to pitch their translational R&D project to the ISAR jury in a confidential ISAR satellite session at BioVaria 2019. The winning ISAR R&D proposal will be announced and honored with € 2,000 at the ISAR award ceremony held at BioVaria 2019 and will be further evaluated whether it is eligible for ISAR support and funding. R&D project proposals must be submitted no later than April 12th 2019.
Further information and application instructions see competition website.